Debt-to-equity ratio rose to 1.33 in Q2 2026 from 0.96 in Q1 2024, while retained earnings fell $2.8B to $7.0B, reflecting cumulative losses and a strained capital structure.
LyondellBasell Industries N.V. (LYB) balance sheet — 18-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 |
|---|
| Total Current Assets | 11.66B | 10.87B | 12.27B | 13.15B | 11.85B | 12.22B | 11.63B | 9.51B | 10.57B | 11.74B | 9.6B | 9.79B | 11.64B | 14.6B | 12.29B | 11.44B | 13.78B | 8.27B | 7.44B |
| Cash & Short-Term Investments | 2.63B | 3.45B | 3.38B | 3.39B | 2.15B | 1.48B | 2.46B | 1.05B | 1.22B | 2.83B | 2.02B | 1.99B | 2.62B | 4.45B | 2.73B | 1.06B | 4.22B | 569M | 890M |
| Cash Only | 2.63B | 3.45B | 3.38B | 3.39B | 2.15B | 1.47B | 1.76B | 858M | 332M | 1.52B | 875M | 924M | 1.03B | 4.45B | 2.73B | 1.06B | 4.22B | 558M | 858M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 9M | 702M | 196M | 892M | 1.31B | 1.15B | 1.06B | 1.59B | 0 | 0 | 0 | 0 | 11M | 32M |
| Accounts Receivable | 3.97B | 2.81B | 3.55B | 3.99B | 4.08B | 5.21B | 4.49B | 3.46B | 4.43B | 4.32B | 3.4B | 3.25B | 4.02B | 4.5B | 4.21B | 4.54B | 3.75B | 3.29B | 2.58B |
| Days Sales Outstanding | 38.21 | 34.06 | 32.15 | 35.42 | 29.52 | 41.2 | 59.04 | 36.31 | 41.49 | 45.75 | 42.49 | 36.19 | 32.14 | 37.29 | 33.87 | 34.37 | 33.23 | 38.92 | 18.61 |
| Inventory | 4.08B | 3.6B | 4.66B | 4.76B | 4.8B | 4.9B | 4.34B | 4.59B | 4.51B | 4.22B | 3.81B | 4.05B | 4.52B | 5.28B | 5.08B | 5.5B | 4.82B | 3.28B | 3.31B |
| Days Inventory Outstanding | 52.98 | 47.94 | 47.57 | 48.52 | 39.99 | 47.83 | 65.09 | 57.15 | 50.66 | 54.86 | 59.95 | 57.57 | 42.34 | 50.79 | 46.78 | 46.97 | 47.46 | 40.72 | 24.8 |
| Other Current Assets | 10M | 970M | 564M | 882M | 716M | 533M | 184M | 294M | 246M | 192M | 183M | 116M | 182M | 140M | 152M | 198M | 0 | 0 | 0 |
| Total Non-Current Assets | 22.82B | 23.14B | 23.48B | 23.85B | 24.52B | 24.52B | 23.77B | 20.93B | 17.71B | 14.47B | 13.84B | 12.97B | 12.58B | 12.7B | 11.93B | 11.4B | 11.71B | 19.5B | 21.21B |
| Property, Plant & Equipment | 17.18B | 17.35B | 16.53B | 17.08B | 17.11B | 16.5B | 15.88B | 15.6B | 12.48B | 11B | 10.14B | 8.99B | 8.76B | 8.46B | 7.7B | 7.33B | 7.19B | 15.15B | 16.39B |
| Fixed Asset Turnover | 1.85x | 1.74x | 2.44x | 2.41x | 2.95x | 2.80x | 1.75x | 2.23x | 3.13x | 3.14x | 2.88x | 3.64x | 5.21x | 5.21x | 5.89x | 6.57x | 5.72x | 2.03x | 3.09x |
| Goodwill | 705M | 708M | 1.56B | 1.65B | 1.83B | 1.88B | 1.95B | 1.89B | 1.81B | 570M | 528M | 536M | 566M | 605M | 591M | 585M | 787M | 0 | 0 |
| Intangible Assets | 394M | 450M | 577M | 641M | 662M | 695M | 751M | 869M | 965M | 568M | 550M | 640M | 769M | 904M | 1.04B | 1.18B | 1.36B | 1.86B | 2.24B |
| Long-Term Investments | 15.85B | 3.97B | 4.12B | 3.91B | 4.29B | 4.79B | 4.73B | 2.11B | 2.1B | 2.07B | 2.01B | 2.13B | 2.06B | 2.11B | 2.36B | 2.04B | 2.09B | 2.12B | 2.38B |
| Other Non-Current Assets | 658M | 451M | 429M | 381M | 467M | 493M | 419M | 423M | 322M | 171M | 426M | 469M | 148M | 262M | 202M | 246M | 287M | 377M | 202M |
| Total Assets | 34.48B | 34B | 35.75B | 37B | 36.37B | 36.74B | 35.4B | 30.43B | 28.28B | 26.21B | 23.44B | 22.76B | 24.22B | 27.3B | 24.22B | 22.84B | 25.49B | 27.76B | 28.65B |
| Asset Turnover | 0.92x | 0.89x | 1.13x | 1.11x | 1.39x | 1.26x | 0.78x | 1.14x | 1.38x | 1.32x | 1.24x | 1.44x | 1.88x | 1.61x | 1.87x | 2.11x | 1.61x | 1.11x | 1.77x |
| Asset Growth % | -20.16% | -4.88% | -3.39% | 1.75% | -1.03% | 3.78% | 16.32% | 7.63% | 7.91% | 11.79% | 3.01% | -6.04% | -11.27% | 12.71% | 6.05% | -10.41% | -8.17% | -3.11% | - |
| Total Current Liabilities | 7.11B | 6.13B | 6.71B | 7.15B | 6.76B | 7.23B | 5.5B | 5.2B | 5.51B | 4.78B | 4.54B | 4.35B | 5.44B | 5.51B | 5.1B | 5.02B | 4.76B | 10.37B | 28.6B |
| Accounts Payable | 2.74B | 2.69B | 3.73B | 3.81B | 3.58B | 4.29B | 2.4B | 2.52B | 2.56B | 2.26B | 2.03B | 1.63B | 2.24B | 2.82B | 2.44B | 2.56B | 1.97B | 1.63B | 2.42B |
| Days Payables Outstanding | 37.93 | 35.84 | 38.12 | 38.84 | 29.83 | 41.88 | 35.93 | 31.34 | 28.73 | 29.37 | 31.92 | 23.12 | 20.99 | 27.15 | 22.49 | 21.88 | 19.36 | 20.22 | 18.09 |
| Short-Term Debt | 1.7B | 1.18B | 617M | 899M | 781M | 368M | 671M | 448M | 890M | 70M | 596M | 357M | 350M | 59M | 96M | 52M | 46M | 6.68B | 23.66B |
| Deferred Revenue (Current) | 113M | 113M | 110M | 175M | 167M | 169M | 157M | 103M | 128M | 61M | 22M | 57M | 73M | 107M | 34M | 41M | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 1.58B | 473M | 595M | 232M | 251M | 334M | 444M | 283M | 277M | 113M | 108M | 539M | 660M | 653M | 459M | 244M | 170M | 236M |
| Current Ratio | 1.64x | 1.77x | 1.83x | 1.84x | 1.75x | 1.69x | 2.11x | 1.83x | 1.92x | 2.46x | 2.11x | 2.25x | 2.14x | 2.65x | 2.41x | 2.28x | 2.90x | 0.80x | 0.26x |
| Quick Ratio | 1.07x | 1.19x | 1.13x | 1.17x | 1.04x | 1.01x | 1.32x | 0.95x | 1.10x | 1.57x | 1.28x | 1.32x | 1.31x | 1.69x | 1.42x | 1.18x | 1.88x | 0.48x | 0.14x |
| Cash Conversion Cycle | 53.26 | 46.17 | 41.61 | 45.09 | 39.69 | 47.15 | 88.2 | 62.12 | 63.43 | 71.23 | 70.52 | 70.64 | 53.49 | 60.92 | 58.16 | 59.46 | 61.33 | 59.42 | 25.31 |
| Total Non-Current Liabilities | 16.58B | 17.67B | 16.45B | 16.79B | 16.86B | 17.52B | 21.8B | 17.06B | 12.37B | 12.48B | 12.83B | 11.83B | 10.44B | 9.27B | 7.95B | 7.17B | 9.14B | 26.24B | 6B |
| Long-Term Debt | 11.21B | 13.45B | 10.53B | 10.33B | 10.54B | 11.25B | 15.29B | 11.61B | 8.5B | 8.55B | 8.38B | 7.67B | 6.7B | 5.78B | 4.3B | 3.98B | 6.04B | 305M | 304M |
| Capital Lease Obligations | 5.33B | 1.33B | 1.42B | 1.41B | 1.51B | 1.65B | 1.22B | 1.22B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 9.31B | 2.32B | 2.54B | 2.89B | 2.86B | 2.33B | 2.33B | 2.02B | 1.98B | 1.66B | 2.33B | 2.13B | 1.62B | 1.66B | 1.31B | 917M | 923M | 2.08B | 3.24B |
| Other Non-Current Liabilities | 1.7B | 573M | 1.97B | 2.16B | 1.95B | 2.29B | 2.96B | 2.21B | 1.9B | 2.27B | 2.11B | 2.04B | 2.12B | 1.84B | 2.33B | 2.28B | 2.18B | 23.86B | 2.45B |
| Total Liabilities | 23.8B | 23.8B | 23.16B | 23.94B | 23.62B | 24.75B | 27.3B | 22.26B | 17.88B | 17.26B | 17.37B | 16.18B | 15.88B | 14.78B | 13.04B | 12.19B | 13.9B | 36.61B | 34.6B |
| Total Debt | 14.22B | 15.96B | 12.92B | 13B | 13.18B | 13.6B | 17.49B | 13.55B | 9.39B | 8.62B | 8.98B | 8.03B | 7.04B | 5.83B | 4.4B | 4.03B | 6.08B | 6.98B | 23.97B |
| Net Debt | 11.59B | 12.51B | 9.55B | 9.61B | 11.02B | 12.13B | 15.73B | 12.69B | 9.05B | 7.1B | 8.11B | 7.1B | 6.01B | 1.39B | 1.67B | 2.97B | 1.86B | 6.43B | 23.11B |
| Debt / Equity | 1.33x | 1.56x | 1.03x | 1.00x | 1.03x | 1.13x | 2.16x | 1.66x | 0.90x | 0.96x | 1.48x | 1.22x | 0.84x | 0.47x | 0.39x | 0.38x | 0.52x | - | - |
| Debt / EBITDA | 5.84x | 15.02x | 3.87x | 2.83x | 2.07x | 1.67x | 5.94x | 2.50x | 1.45x | 1.30x | 1.47x | 1.12x | 1.04x | 0.95x | 0.78x | 0.77x | 1.50x | 3.34x | - |
| Net Debt / EBITDA | 4.76x | 11.77x | 2.86x | 2.10x | 1.73x | 1.49x | 5.34x | 2.34x | 1.40x | 1.07x | 1.32x | 0.99x | 0.89x | 0.23x | 0.29x | 0.56x | 0.46x | 3.07x | - |
| Interest Coverage | 0.94x | -0.40x | 4.33x | 6.51x | 17.64x | 14.08x | 3.63x | 12.68x | 15.75x | 12.19x | 17.25x | 21.03x | 17.23x | 17.17x | 7.39x | 4.38x | 8.21x | -1.39x | -2.31x |
| Total Equity | 10.68B | 10.21B | 12.59B | 13.06B | 12.74B | 11.99B | 8.1B | 8.18B | 10.4B | 8.95B | 6.07B | 6.57B | 8.34B | 12.51B | 11.18B | 10.65B | 11.6B | -8.85B | -5.95B |
| Equity Growth % | -70.29% | -18.91% | -3.6% | 2.47% | 6.3% | 47.93% | -0.92% | -21.33% | 16.16% | 47.37% | -7.62% | -21.21% | -33.32% | 11.94% | 5% | -8.18% | 231.07% | -48.79% | - |
| Book Value per Share | 33.07 | 31.70 | 38.61 | 40.06 | 38.85 | 35.89 | 24.26 | 23.17 | 26.72 | 22.43 | 14.46 | 14.11 | 16.02 | 21.95 | 19.37 | 18.61 | 20.49 | -15.69 | -10.54 |
| Total Shareholders' Equity | 10.67B | 10.08B | 12.46B | 12.93B | 12.62B | 11.86B | 7.97B | 8.04B | 10.26B | 8.95B | 6.05B | 6.55B | 8.31B | 12.48B | 11.14B | 10.59B | 11.54B | -8.98B | -6.08B |
| Common Stock | 19M | 19M | 19M | 19M | 19M | 19M | 19M | 19M | 22M | 31M | 31M | 31M | 31M | 31M | 31M | 31M | 30M | 60M | 60M |
| Retained Earnings | 7.04B | 6.81B | 9.32B | 9.69B | 9.2B | 8.56B | 4.44B | 4.43B | 6.76B | 15.75B | 12.28B | 9.84B | 6.78B | 4B | 1.27B | 841M | 1.59B | -9.31B | -6.44B |
| Treasury Stock | -1.5B | -1.59B | -1.5B | -1.45B | -1.35B | -965M | -531M | -580M | -2.21B | -15.75B | -14.95B | -12.09B | -7.85B | -2.04B | -106M | -124M | 0 | 0 | 0 |
| Accumulated OCI | -1.02B | -1.31B | -1.53B | -1.48B | -1.37B | -1.8B | -1.94B | -1.78B | -1.36B | -1.28B | -1.51B | -1.44B | -1.03B | 96M | -411M | -427M | 81M | -286M | -264M |
| Minority Interest | 9M | 125M | 126M | 128M | 128M | 130M | 133M | 135M | 139M | 1M | 25M | 24M | 30M | 36M | 40M | 54M | 61M | 129M | 135M |
Quick answers to the most common questions about buying LYB stock.
As of 2025, LyondellBasell Industries N.V. (LYB) had total assets of $34.00B including $10.87B in current assets.
LyondellBasell Industries N.V. (LYB) carries total debt of $15.96B, offset by $3.45B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
LyondellBasell Industries N.V. (LYB) has total shareholders' equity (book value) of $10.08B ($31.70 book value per share). Book value represents the net worth of the company belonging to common stock holders.
LyondellBasell Industries N.V. (LYB) reported a current ratio of 1.77x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Dividend sustainability amid cyclical trough
Metrics are mathematically derived from official filings.
Balance Sheet Erosion Reflects Cyclical Stress
Total assets fell from $37.1B in 2024Q2 to $34.5B in 2026Q2, while equity dropped from $13.4B to $10.7B, indicating a weakening balance sheet. According to quarterly disclosures, the decline is driven by cumulative losses and asset write-downs.
The sequential decline in equity, from $13.4B in 2024Q2 to $10.7B in 2026Q2, is consistent with the negative net income reported over the period. The reduction in total assets, despite a relatively stable PPE base, suggests that the company is not expanding its asset base, which may indicate a defensive posture. The trajectory implies that the balance sheet is absorbing the cyclical downturn, but the pace of erosion appears to be slowing, as equity stabilized between 2026Q1 and 2026Q2.
Leverage Rises as Debt Load Persists
Total debt increased from $12.6B in 2024Q1 to $14.2B in 2026Q2, while equity contracted, pushing the debt-to-equity ratio from 0.96 to 1.33. As reported in financial statements, the leverage increase is a result of debt remaining elevated while equity shrinks.
The debt-to-equity ratio has risen from 0.96 in 2024Q1 to 1.33 in 2026Q2, reflecting both higher absolute debt and a shrinking equity base. The absolute debt level has remained above $12.6B throughout the period, indicating that the company has not meaningfully deleveraged despite the downturn. This suggests that the company may be relying on debt to fund its dividend and capital expenditures, which could strain cash flow if the downturn persists. The D/E ratio of 1.33 is higher than peers like Dow (1.12) and Westlake (0.69), indicating a relatively higher leverage position.
Asset Mix Shifts with Goodwill Impairment
Goodwill fell from $1.6B in 2024Q1 to $705M in 2026Q2, a 56% reduction, while PPE remained stable around $17B. Based on reported figures, the goodwill write-down suggests an impairment in the Advanced Polymer Solutions segment.
The sharp decline in goodwill from $1.6B to $705M indicates a significant impairment charge, likely related to the Advanced Polymer Solutions acquisition, which has faced integration challenges. This impairment reduces the quality of assets, as a larger portion of the balance sheet is now tied to physical assets. The stability of PPE at around $17B suggests that the company is maintaining its asset base, but the impairment signals that past acquisitions have not generated the expected returns. The asset mix is becoming more heavily weighted toward tangible assets, which may reduce flexibility in a downturn.
Retained Earnings Drain Undermines Equity
Retained earnings fell from $9.8B in 2024Q1 to $7.0B in 2026Q2, a cumulative decline of $2.8B, reflecting sustained losses. As reported in financial statements, the decline in retained earnings is consistent with negative net income over the period.
The decline in retained earnings from $9.8B to $7.0B over the ten quarters indicates that the company has been distributing more to shareholders than it is earning. This is corroborated by the negative net income in several quarters and the consistent dividend payments. The erosion of retained earnings reduces the equity buffer and may limit the company's ability to absorb future shocks. The negative ROE of -6.5% in 2026Q2 further underscores the strain on equity returns.
Liquidity Buffer Thins Despite Stable Cash
Cash remained stable at $2.6B in 2026Q2, but the current ratio fell from 2.12 in 2024Q1 to 1.64, indicating a tighter liquidity position. According to quarterly data, the decline is driven by rising current liabilities.
The current ratio has declined from 2.12 to 1.64 over the period, suggesting that current liabilities have grown faster than current assets. While cash has remained around $2.6B, the company's ability to cover short-term obligations has weakened. This may indicate increased reliance on short-term debt or trade credit. The liquidity buffer appears adequate for now, but the trend warrants monitoring, especially if operating cash flow remains negative.
LIFO and JV Distortions Mask True Leverage
The reported D/E of 1.33 may understate economic leverage because the company uses LIFO inventory accounting and has significant equity-method joint ventures. Based on reported figures, these off-balance-sheet items could obscure the true debt burden.
The use of LIFO inventory accounting can create non-cash fluctuations in earnings and inventory values, potentially distorting the balance sheet. Additionally, the company's extensive use of equity-method joint ventures means that a portion of its operational footprint and associated debt is not consolidated. This could understate the company's true leverage and risk. Investors should consider these factors when assessing the balance sheet's resilience, as the headline numbers may not fully capture the company's financial obligations.